...
首页> 外文期刊>Chinese journal of cancer >A curative-intent endoscopic surgery for postradiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma
【24h】

A curative-intent endoscopic surgery for postradiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma

机译:鼻咽癌放疗后鼻咽坏死的根治性内镜手术

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Postradiation nasopharyngeal necrosis (PRNN) is a severe complication after radiotherapy in patients with nasopharyngeal carcinoma (NPC), which can severely affect the quality of life and threaten the patient’s life. Only 13.4%–28.6% of patients can be cured by traditional repeated endoscopic debridement. Here, we introduced an innovative curative-intent endoscopic surgery for PRNN patients and evaluated its clinical efficacy. Methods Clinical data of 72 PRNN patients who underwent radical endoscopic necrectomy, followed by reconstruction using a posterior pedicle nasal septum and floor mucoperiosteum flap were analyzed to determine the efficacy of this surgery. The endpoints were complete re-epithelialization of the nasopharyngeal defect, relief of headache, and overall survival (OS). Results All surgeries were successfully performed without any severe postoperative complications or death. The median value of numeric rating scales of pain decreased from 8 before surgery to 0 after surgery ( P ?0.001). Fifty-one patients (70.8%) achieved complete re-epithelialization of the nasopharyngeal defect. The number of cycles of radiotherapy (odds ratio [OR], 7.254; 95% confidence interval [CI] 1.035–50.821; P =?0.046), postoperative pathological result (OR, 34.087; 95% CI 3.168–366.746; P =?0.004), and survival status of flap (OR, 261.179; 95% CI 17.176–3971.599; P ?0.001) were independent risk factors of re-epithelialization of the nasopharyngeal defects. Postoperative pathological result (hazard ratio [HR], 5.018; 95% CI 1.970–12.782; P =?0.001) was an independent prognostic factor for OS. The 2-year OS rate of the entire cohort was 77.9%. Conclusion Curative-intent endoscopic necrectomy followed by construction using the posterior pedicle nasal septum and floor mucoperiosteum flap is a novel, safe, and effective treatment of PRNN in patients with NPC.
机译:背景放射治疗后的鼻咽坏死(PRNN)是鼻咽癌(NPC)患者放疗后的严重并发症,可能严重影响生活质量并威胁患者的生命。传统的重复内镜清创术只能治愈13.4%–28.6%的患者。在这里,我们为PRNN患者介绍了一种创新的根治性内窥镜手术,并评估了其临床疗效。方法分析72例PRNN患者行根治性内镜摘除术,然后行椎弓根鼻中隔和底部粘膜骨膜瓣重建术,以确定该手术的有效性。终点是鼻咽缺损的完全上皮再形成,头痛的缓解和总生存期(OS)。结果所有手术均成功完成,无严重的术后并发症或死亡。疼痛数字评分量表的中位数从手术前的8降低到手术后的0(P <0.001)。 51名患者(70.8%)实现了鼻咽缺损的完全上皮再形成。放射治疗的周期数(比值[OR]为7.254; 95%置信区间[CI]为1.035-50.821; P =?0.046),术后病理结果(OR为34.087; 95%CI为3.168-366.746; P =? 0.004)和皮瓣的存活状态(OR,261.179; 95%CI 17.176-3971.599; P <0.001)是鼻咽缺损再上皮化的独立危险因素。术后病理结果(危险比[HR],5.018; 95%CI 1.970–12.782; P =?0.001)是OS的独立预后因素。整个队列的2年OS率为77.9%。结论根治性内镜下肾切除加椎弓根后鼻中隔和底部粘膜骨膜瓣造瘘术是治疗鼻咽癌的一种新颖,安全,有效的方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号